Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/07/08 20:56:18」(JST)

wiki en

[Wiki en表示]

English Journal

  • Molecular characterization of quinolone-insensitive Streptococcus pneumoniae isolates from Japanese patients.
  • Araki N, Yanagihara K, Matsukawa Y, Harada Y, Migiyama Y, Nagaoka K, Yamada K, Morinaga Y, Hasegawa H, Kohno S, Kamihira S.SourceDepartment of Laboratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-7-1 Sakamoto, Nagasaki, 852-8501, Japan.
  • Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.J Infect Chemother.2013 Apr;19(2):356-9. doi: 10.1007/s10156-012-0461-0. Epub 2012 Aug 22.
  • Fluoroquinolone resistance in Streptococcus pneumoniae has become a growing concern. Using S. pneumoniae isolates (n = 61) for which the minimum inhibitory concentration (MIC) of levofloxacin was not less than 1 μg/ml, we investigated the susceptibility of S. pneumoniae isolates to other fluoroq
  • PMID 22911090
  • In vitro activities of levofloxacin, gatifloxacin, moxifloxacin and garenoxacin against Bacteroides fragilis strains evaluated by kill kinetics.
  • Schaumann R, Janssen E, Funke M, Stîngu CS, Genzel GH, Janssen M, Rodloff AC.SourceInstitute for Medical Microbiology and Epidemiology of Infectious Diseases, University of Leipzig, Leipzig, Germany.
  • Journal of medical microbiology.J Med Microbiol.2013 Apr;62(Pt 4):576-81. doi: 10.1099/jmm.0.053280-0. Epub 2013 Jan 14.
  • This study was designed to investigate the killing activity of levofloxacin, gatifloxacin, moxifloxacin and garenoxacin against 12 Bacteroides fragilis strains by kill kinetics over time. MIC values were determined by Etest and by agar dilution. B. fragilis strains were divided according to their MI
  • PMID 23319309

Japanese Journal

  • Pharmacokinetic study of garenoxacin in severe renal failure patients
  • The Japanese journal of antibiotics 68(3), 141-150, 2015-06
  • NAID 40020517292
  • 5.EBUS-TBNAによる縦隔リンパ節中Garenoxacin濃度の測定(第36回 日本呼吸器内視鏡学会北海道支部会)
  • 遠藤 哲史,平井 理子,風林 佳大,南 幸範,奥村 俊介,佐々木 高明,山本 泰司,長内 忍,大崎 能伸
  • 気管支学 : 日本気管支研究会雑誌 36(6), 681, 2014-11-25
  • NAID 110009878738

Related Links

Garenoxacin was discovered by Toyama Chemical Co., Ltd. of Tokyo, Japan, and is currently being marketed in Japan under the tradename Geninax. Schering- Plough holds worldwide rights for garenoxacin, except for Japan, South Korea, ...
日本における発売年. 2007(平成19)年. 3. 特長. 呼吸器・耳鼻咽喉科領域感染症の 主要起炎菌に適した抗菌スペクトルと優れた抗菌活性を有する(in vitro)。 多剤耐性 肺炎球菌にも優れた抗菌活性を示す(in vitro)。 1日1回投与で大きなAUC(血中濃度 曲線 ...

Related Pictures

garenoxacinGarenoxacin.svgGarenoxacin synthesis: [ 7 ] N.B. [ 8 ] Garenoxacin AUC 24 / MHK = 67 Tam et alGarenoxacin mesilate, T-3811ME, BMS-284756 Figure US20120046259A1-20120223-C00028




メシル酸ガレノキサシン水和物 garenoxacin mesilate hydrate